Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
8.30
-0.27 (-3.10%)
Apr 3, 2025, 1:49 PM EDT - Market open
Anavex Life Sciences Employees
Anavex Life Sciences had 42 employees as of September 30, 2024. The number of employees increased by 2 or 5.00% compared to the previous year.
Employees
42
Change (1Y)
2
Growth (1Y)
5.00%
Revenue / Employee
n/a
Profits / Employee
-$1,106,929
Market Cap
705.61M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AVXL News
- 3 days ago - Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference - GlobeNewsWire
- 6 weeks ago - Anavex: Looking At Different Statistical Approaches Before EMA Opinion - Seeking Alpha
- 7 weeks ago - Anavex: Further Validation Of Blarcamesine With Schizophrenia Data In 2025 - Seeking Alpha
- 7 weeks ago - Anavex Life Sciences Corp. (AVXL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025 - GlobeNewsWire
- 2 months ago - Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio - GlobeNewsWire